DOCK4 and ovarian cancer: Given that DOCK4, the promising biomarker for prognosis of ovarian cancer patients, could be detected in blood contributing to clinical treatment, we then investigated the expression pattern of DOCK4 in blood samples consistent with DOCK4 encoding a secreted protein.